The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFocusrite Regulatory News (TUNE)

Share Price Information for Focusrite (TUNE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 357.50
Bid: 350.00
Ask: 365.00
Change: 6.00 (1.69%)
Spread: 15.00 (4.286%)
Open: 357.50
High: 360.00
Low: 360.00
Prev. Close: 354.00
TUNE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update for the year ended 31 August 2023

14 Sep 2023 07:00

RNS Number : 3678M
Focusrite PLC
14 September 2023
 

Strictly embargoed until 07.00, 14 September 2023

Focusrite plc

("Focusrite" or "the Group")

Trading Update for the year ended 31 August 2023

Focusrite plc (AIM: TUNE), the global music and audio products group supplying hardware and software used by audio professionals and musicians, is pleased to provide the following update on trading for the year ended 31 August 2023 (FY23).

Despite challenging markets, particularly in Asia, the Group is still showing material growth over pre pandemic levels and has retained its strong market share, supported by 28 product introductions, most notably a new generation of Scarlett, the market leading range of Focusrite audio interfaces, which launched on 31 August 2023. Within the Content Creation division, the Focusrite brands returned to growth in H2 FY23 compared with H2 FY22 whilst the Audio Reproduction division continued to grow by a double-digit percentage. Overall, revenue for the Group in H2 FY23 was slightly ahead of the comparable period in FY22. As a result, Group revenue for FY23 is expected to be not less than £177 million (FY22: £184 million). Supported by improved gross margins, our expectations are for EBITDA1 for the full year to be around the lower end of current market expectations, which currently range between £38.2 million and £39.0 million.

As at 31 August 2023 the Group had net debt2 of approximately £1.5 million (FY22: net debt £0.3 million, FY23 H1: net debt £13.2 million). This includes the acquisition of Sonnox Ltd in December 2022 for a net cash consideration of £7.2 million. Working capital has improved significantly in the second half as inventory in the channel has reduced as expected to more normal levels. 

The Group expects to announce its audited final results for the year ended 31 August 2023 in late November 2023.

Tim Carroll, Chief Executive commented:

"We are pleased with our full year results and the strategic progress the Group is making against the background of extremely challenging trading conditions throughout the year. Our fourth generation of Scarlett has been launched to critical acclaim, and well received in the sales channel, reflecting the investment and innovation which have made this product the market leader. Inventory in the channel for our Content Creation brands continues to unwind with levels returning to historic norms as we approach the winter holiday season. Our Audio Reproduction businesses have continued to show good growth, reflecting the continued returning demand for live sound and events across the globe. We remain mindful of current industry wide macro-economic factors, though we believe we are well placed to manage them accordingly."

 

1 EBITDA defined as earnings adjusted for interest, taxation, depreciation and amortisation.

2 Net debt defined as cash and cash equivalents, overdrafts and amounts drawn against the Revolving Credit Facility (RCF) including the costs of arranging the RCF.

-Ends-

 

Enquiries:

 

 

Focusrite plc:

 

Tim Carroll (CEO)

+44 1494 462246

Sally McKone (CFO)

+44 1494 462246

 

 

Investec Bank plc (Nominated Adviser and Joint Broker)

David Flin

Edward Knight

William Brinkley

 

Peel Hunt LLP (Joint broker)

Paul Gillam

Michael Burke

James Smith

 

+44 20 7597 5970

 

 

 

 

+44 20 7418 8900

Belvedere Communications

John West

Llew Angus

 +44 20 3008 6864

 

 

 

 

Notes to Editors

Focusrite plc is a global audio products group that develops and markets proprietary hardware and software products. Used by audio professionals and musicians, its solutions facilitate the high-quality production of recorded and live sound. The Group trades under eleven established brands: Focusrite, Focusrite Pro, Novation, Ampify, ADAM Audio, Martin Audio, Optimal Audio, Linea Research, Sequential, Oberheim and Sonnox.

With a high-quality reputation and a rich heritage spanning decades, its brands are category leaders in the music-making and audio recording industries. Focusrite and Focusrite Pro design and manufacture audio interfaces and other products for recording musicians, producers and professional audio facilities. Novation and Ampify products are used in the creation of electronic music, from synthesisers and grooveboxes to industry-shaping controllers and inspirational music-making apps. ADAM Audio studio monitors have earned a worldwide reputation based on technological innovation in the field of studio loudspeaker technology. Martin Audio designs and manufactures performance-ready systems across the spectrum of sound reinforcement applications. Linea Research designs, develops, manufactures and sells market innovative professional audio equipment globally. Sequential designs and manufactures high end analogue synthesizers under the Sequential and Oberheim brands. Sonnox is a leading designer of innovative, high quality, award-winning audio processing software plug-ins for professional audio engineers.

The Group has offices in four continents and a global customer base with a distribution network covering approximately 240 territories.

Focusrite plc is traded on the Alternative Investment Market (AIM) of the London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUOUNROVUKAAR
Date   Source Headline
25th Apr 20247:00 amRNSInterim Results
22nd Apr 20246:09 pmRNSTR-1
9th Apr 20247:00 amRNSInvestor Presentation via Investor Meet Company
8th Apr 20247:00 amRNSNotice of Interim Results
22nd Mar 20243:36 pmRNSNotification of PDMR Transactions
22nd Mar 20248:01 amRNSTR-1
20th Mar 20247:01 amRNSTR-1
19th Mar 20244:44 pmRNSNotification of PDMR Transactions
18th Mar 20247:00 amRNSTrading Update
14th Feb 20243:10 pmRNSNotification of PDMR Transactions
7th Feb 20242:25 pmRNSTR-1
19th Jan 202412:59 pmRNSResult of AGM
19th Jan 20247:00 amRNSAGM Statement
8th Jan 20244:36 pmRNSTR-1
2nd Jan 20247:00 amRNSPHIL DUDDERIDGE AWARDED OBE
19th Dec 20237:00 amRNSAcquisition of Sheriff Technology Limited
7th Dec 20233:58 pmRNSTR-1
5th Dec 20232:02 pmRNSGrant of Share Options to PDMRs
5th Dec 20231:54 pmRNSDirector Share Dealings
29th Nov 20234:51 pmRNSTR-1
28th Nov 20237:00 amRNSFinal Results
17th Nov 202310:27 amRNSTR-1
17th Nov 20237:00 amRNSTR-1
7th Nov 20237:00 amRNSTR-1
31st Oct 20237:00 amRNSNotice of Final Results
14th Sep 20237:00 amRNSTrading Update for the year ended 31 August 2023
9th Jun 202310:54 amRNSNotification of PDMR Transactions
16th May 20237:20 amRNSChange of Registered Office
3rd May 20237:00 amRNSPDMR Dealings
26th Apr 20232:39 pmRNSInterim Dividend Timetable Correction
25th Apr 20237:00 amRNSHalf year results
11th Apr 20231:28 pmRNSNotice of Interim Results
14th Mar 20237:00 amRNSTrading Update
22nd Feb 20239:25 amRNSNotification of PDMR Transactions
7th Feb 20239:51 amRNSPDMR Dealings
3rd Feb 202312:49 pmRNSResult of AGM
3rd Feb 20237:00 amRNSAGM Statement and Update on Trading
18th Jan 20237:00 amRNSSettlement of Share Options
18th Jan 20237:00 amRNSNotification of PDMR Transaction
16th Jan 202311:43 amRNSSettlement of Share Options
22nd Dec 202211:49 amRNSGrant of Share Options to PDMRs
20th Dec 20227:00 amRNSAcquisition of Sonnox Limited
14th Dec 20227:00 amRNSPDMR
8th Dec 20229:05 amRNSSecond Price Monitoring Extn
8th Dec 20229:00 amRNSPrice Monitoring Extension
8th Dec 20227:00 amRNSFinal Results
7th Dec 202211:12 amRNSShare issuance to Employee Benefit Trust
21st Nov 20227:00 amRNSChange to Final Results announcement date
7th Nov 20227:00 amRNSNotice of Final Results
27th Oct 20221:37 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.